{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:09:20Z","timestamp":1790636960662,"version":"4.1.0"},"reference-count":0,"publisher":"OAE Publishing Inc.","content-domain":{"domain":["oaepublish.com"],"crossmark-restriction":false},"short-container-title":["CDR"],"DOI":"10.20517\/cdr.2019.96","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T05:43:33Z","timestamp":1583991813000},"update-policy":"https:\/\/doi.org\/10.20517\/oae.crossmark.policy","source":"Crossref","is-referenced-by-count":10,"title":["Gene silencing of HIF-2\u03b1 disrupts glioblastoma stem cell phenotype"],"prefix":"10.20517","author":[{"given":"Leora M.","family":"Nusblat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaili","family":"Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8410","published-online":{"date-parts":[[2020]]},"container-title":["Cancer Drug Resistance"],"original-title":[],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T08:43:45Z","timestamp":1705567425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2019.96"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":0,"URL":"https:\/\/doi.org\/10.20517\/cdr.2019.96","relation":{},"subject":[],"published":{"date-parts":[[2020]]}}}